Bayer | BAYN - Equity Capital And Reserves


Bayer reported EUR29.71B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Air Liquide EUR 26.52B 303.1M Jun/2026
Akzo Nobel EUR 4.85B 28M Jun/2026
Alcon AG USD 21.6B 538M Jun/2026
Amarin USD 443.62M 5.8M Jun/2026
Arkema EUR 6.78B 176.8M Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
BASF EUR 36.32B 846M Jun/2026
Bayer EUR 29.71B 863M Jun/2026
Beiersdorf EUR 8.6B 133M Dec/2025
Corteva USD 25.16B 797M Jun/2026
Covestro EUR 7B 908M Dec/2025
Essilor EUR 39.22B 329M Jun/2026
Fresenius EUR 19.7B 766M Jun/2026
Fresenius Medical Care EUR 13.53B 673.44M Jun/2026
Genmab DKK 5.96B 275M Jun/2026
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Henkel EUR 20.97B 479M Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Johnson Matthey GBP 2.02B 85M Jun/2026
Linde USD 40.09B 1.85B Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 30.17B 430M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Nutrien USD 25.9B 748M Jun/2026
Philips EUR 11.48B 84M Jun/2026
PPG Industries USD 8.59B 486M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
SAP EUR 44.74B 117M Jun/2026
Solvay EUR 1.11B 70M Jun/2026
UCB EUR 10.87B 1.18B Dec/2025
Umicore EUR 2.66B 424.8M Jun/2026
Vinci EUR 30.59B 3.74B Jun/2026